|
|
|
21.10.26 - 14:01
|
Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026 (GlobeNewswire EN)
|
|
|
FOSTER CITY, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today announced that it will release its third quarter 2026 financial results and business highlights before the market opens on Wednesday, November 4, 2026, via press release, which will be available on the Investors section of the Company's website. Geron will host a conference call and webcast at 8:00 a.m. Eastern Time....
|
|
|
19.10.26 - 22:02
|
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
|
|
|
FOSTER CITY, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today reported that, effective October 16, 2026, it granted stock options to purchase an aggregate of 570,000 shares of common stock to three newly hired employees as an inducement material to such employees' acceptance of employment with Geron....
|
|
|
|
|
|
|
07.10.26 - 08:00
|
Geron-Aktie mit -98% – große Chance oder großes Risiko? (Sharedeals)
|
|
|
Die Geron-Aktie notiert aktuell bei 1,21 US$ und befindet sich erneut an einer langfristig wichtigen Unterstützungszone. Seit dem Zwischenhoch von 2024 hat der Biotech-Titel rund drei Viertel seines Wertes verloren. Gleichzeitig drehen RSI und MACD wieder nach unten. Droht nun der Bruch der psychologisch wichtigen Marke von 1,00 US$? Chartanalyse zur Geron-Aktie Die Geron-Aktie bewegt […]
The post Geron-Aktie mit -98% – große Chance oder großes Risiko? first appeared on sharedeals.de....
|
|
|
|
|
|
|
|
|
|
|
|
|
12.08.26 - 12:36
|
Swedish PM Calls Spanish Illegal Immigrant Amnesty ′Very Bad Idea′ (ZeroHedge)
|
|
|
Swedish PM Calls Spanish Illegal Immigrant Amnesty 'Very Bad Idea'
Authored by Guy Birchall via The Epoch Times,
Swedish Prime Minister Ulf Kristersson has called the Spanish government's amnesty for illegal immigrants a "very bad idea," warning that it could spark another migrant crisis akin to the one that beset the continent in 2015.
Swedish Prime Minister Ulf Kristersson in Brussels on Dec. 19, 2024. Johanna Geron/Reuters
The center-right politician, who is running for reelection next month, told the Financial Times in an interview published on Aug. 11 that the Spanish amnesty for more than a million illegal immigrants had caused a "pretty big outcry" at the last summit of EU leaders.
Spanish Prime Minister Pedro Sánchez's government granted a royal decree on April 14, launching the regularization of people living illegally in the country.
The proposal was first presented on Jan. 27 to allow about 500,000 illegal immigrants already living and working in Spain to ob...
|
|
|
|
|
|
|
|
|
|
|
|
|
22.07.26 - 22:03
|
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
|
|
|
FOSTER CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective July 17, 2026, it granted stock options to purchase an aggregate of 202,500 shares of common stock to five newly hired employees as an inducement material to such employees' acceptance of employment with Geron....
|
|
|
22.07.26 - 13:03
|
Geron Plans to Announce Second Quarter 2026 Financial Results on August 5, 2026 (GlobeNewswire EN)
|
|
|
FOSTER CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that it will release its second quarter 2026 financial results and business highlights before the market opens on Wednesday, August 5, 2026, via press release, which will be available on the Investors and Media section of the Company's website. Geron will host a conference call and webcast at 8:00 a.m. Eastern Time....
|
|
|
14.07.26 - 22:30
|
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
|
|
|
FOSTER CITY, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it granted an equity award in the form of a stock option to purchase 1,700,000 shares of Geron common stock to Chinmaya Rath, Geron's new Chief Business Officer, as an inducement material to his acceptance of employment with Geron....
|
|
|
|